Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (131-140 of 1,022) with videos related to

Pageof 103
Sort By:
Journal of Thrombosis and Thrombolysis|February 7, 2001
Combination Hemotherapy and Mortality Prevention (CHAMP) Study Rationale and DesignFiore, Brophy, Peduzzi, et al.
The American Journal of Cardiology|August 6, 2013
Applying antithrombotic therapies to improve outcomes in patients with atrial fibrillationChris Cannon, Michael D Ezekowitz, Christopher Granger
JACC. Heart Failure|May 7, 2025
Revisiting ICD Therapy for Primary Prevention: The CONTEMP-ICD TrialIlan Goldenberg, Justin A Ezekowitz, Javed Butler
The Journal of Experimental Medicine|February 1, 1983
Macrophage activation selectively enhances expression of Fc receptors for IgG2aR A Ezekowitz, M Bampton, S Gordon
The Journal of Experimental Medicine|May 1, 1989
The human mannose-binding protein functions as an opsoninM Kuhlman, K Joiner, R A Ezekowitz
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1983
Macrophage plasma membrane and activationR A Ezekowitz, M Hill, S Gordon
JAMA Cardiology|February 20, 2020
Pragmatic vs Explanatory Trials-ReplyNariman Sepehrvand, Wendimagegn Alemayehu, Justin A Ezekowitz
Pediatric Research|August 24, 2001
Toll-like receptors as sensors of pathogensM Hallman, M Rämet, R A Ezekowitz
Journal of the American College of Cardiology|April 11, 2020
Left Ventricular Thrombi: Uncommon But Clinically ImportantMichael D Ezekowitz, Daniel Kurz, Anthony Kent
The Journal of Invasive Cardiology|May 21, 2004
Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart diseaseHeidar Arjomand, Marc Cohen, Michael D Ezekowitz
Pageof 103

Showing results (131-140 of 1,022) with videos related to

Sort By:
Pageof 103
Journal of Thrombosis and Thrombolysis|February 7, 2001
Combination Hemotherapy and Mortality Prevention (CHAMP) Study Rationale and DesignFiore, Brophy, Peduzzi, et al.
The American Journal of Cardiology|August 6, 2013
Applying antithrombotic therapies to improve outcomes in patients with atrial fibrillationChris Cannon, Michael D Ezekowitz, Christopher Granger
JACC. Heart Failure|May 7, 2025
Revisiting ICD Therapy for Primary Prevention: The CONTEMP-ICD TrialIlan Goldenberg, Justin A Ezekowitz, Javed Butler
The Journal of Experimental Medicine|February 1, 1983
Macrophage activation selectively enhances expression of Fc receptors for IgG2aR A Ezekowitz, M Bampton, S Gordon
The Journal of Experimental Medicine|May 1, 1989
The human mannose-binding protein functions as an opsoninM Kuhlman, K Joiner, R A Ezekowitz
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1983
Macrophage plasma membrane and activationR A Ezekowitz, M Hill, S Gordon
JAMA Cardiology|February 20, 2020
Pragmatic vs Explanatory Trials-ReplyNariman Sepehrvand, Wendimagegn Alemayehu, Justin A Ezekowitz
Pediatric Research|August 24, 2001
Toll-like receptors as sensors of pathogensM Hallman, M Rämet, R A Ezekowitz
Journal of the American College of Cardiology|April 11, 2020
Left Ventricular Thrombi: Uncommon But Clinically ImportantMichael D Ezekowitz, Daniel Kurz, Anthony Kent
The Journal of Invasive Cardiology|May 21, 2004
Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart diseaseHeidar Arjomand, Marc Cohen, Michael D Ezekowitz
Pageof 103